Clinical Trials in Arizona

Showing 10181-10200 of 16,770 trials

Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia

NCT00562328

RATIONALE: Monoclonal antibodies, such as rituximab and alemtuzumab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Colony-stimulating factors, such as GM-CSF, may increase the number of immune cells found in bone marrow or peripheral blood. Giving monoclonal antibody therapy together with GM-CSF may be an effective treatment for early-stage chronic lymphocytic leukemia. PURPOSE: This phase II trial is studying the side effects of giving rituximab and alemtuzumab together with GM-CSF and to see how well it works in treating patients with early-stage chronic lymphocytic leukemia.

Leukemia

Mayo Clinic33 participantsStarted Jan 2008

Scottsdale, Arizona, United States • Rochester, Minnesota, United States

COMPLETEDNA31 miles

Use of Peppermint Oil During Screening Colonoscopy to Improve Visibility

NCT03286764

The investigators hypothesize that spraying peppermint oil containing L-menthol onto the colonic mucosa during colonoscopy will relax smooth muscle allowing better colonic visualization.

Enhancement of the ADR During Colonoscopy

Mayo Clinic48 participantsStarted Nov 2016

Scottsdale, Arizona, United States

TERMINATED31 miles

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

NCT03705013

The primary endpoint is to obtain longitudinal information on four sub-populations from the Cologuard Post-Approval Study.

Colorectal Cancer

Exact Sciences Corporation51 participantsStarted Oct 2018

Glendale, Arizona, United States • Mesa, Arizona, United States • Tempe, Arizona, United States +17 more locations

Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia

Use of Peppermint Oil During Screening Colonoscopy to Improve Visibility

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

Find Trials by Condition in Arizona

An Open-Label Trial of PEMF Therapy [Provant Infinity Therapy System] for Home Use in Postoperative Pain

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)

Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II)

Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

Cross Calibration of Two Dual Energy Densitometers and Comparison of Regional Adipose Tissue Measurements by iDXA and MRI

Safety and Efficacy of Bictegravir + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Clinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer Patients

Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)

Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)

Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months

Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL

Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

Thrombelastography Based Dosing of Enoxaparin

Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery